JESSICA SPISSINGER

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant QUINCY, MA NPI 1356599583

General Payments — all program years on this page

$2,176.81

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 107
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $377.35 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $377.3520

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $478.2924
2022 $663.5226
2023 $657.6537
2024 $377.3520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100086362 Corium, LLC $23.77 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100136733 Corium, LLC $1.81 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100193613 Corium, LLC $25.94 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108239730 ABBVIE INC. $23.21 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119191116 Otsuka America Pharmaceutical, Inc. $8.71 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119191118 Otsuka America Pharmaceutical, Inc. $25.83 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119191120 Otsuka America Pharmaceutical, Inc. $2.30 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119191122 Otsuka America Pharmaceutical, Inc. $27.63 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119191124 Otsuka America Pharmaceutical, Inc. $28.75 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119191126 Otsuka America Pharmaceutical, Inc. $22.43 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119191128 Otsuka America Pharmaceutical, Inc. $0.51 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119191130 Otsuka America Pharmaceutical, Inc. $28.12 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120602082 Alkermes, Inc. $21.72 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120602084 Alkermes, Inc. $14.41 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133971048 Vanda Pharmaceuticals Inc. $30.23 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133971050 Vanda Pharmaceuticals Inc. $18.59 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143608612 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.60 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148369555 Axsome Therapeutics, Inc. $13.30 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148369557 Axsome Therapeutics, Inc. $15.97 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151689264 Teva Pharmaceuticals USA, Inc. $24.52 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.